Such features as its actual target antigen were revealed only inconsistently and through secondary sources (such as a series of Michael J Fox Foundation blog posts and a
third - party review article [14]-RRB-, and only hints of their
preclinical studies with the agent were disclosed (mostly [9,11]-RRB-.